Patents by Inventor Takanari Inoue

Takanari Inoue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11951210
    Abstract: This application is directed to methods which allow for encapsulation of an array of biological materials under physiological conditions that are relevant given a biological context and the compositions made using those methods. These reconstituted biological materials encompass: a) purified proteins that can bind to the lipid membranes inside and outside of vesicles based on the electrostatic charge; b) purified cytosolic proteins that position themselves in the lumen of the vesicles, c) mammalian cell extracts with an array of cytosolic protein content, among other contents and d) small biological molecules such as DNA and RNA as well as fluorescent dyes/probes. These vesicles can be used to simulate cells in drug discovery methods as well as useful in administering drugs and other compositions to cells in vitro and in vivo.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: April 9, 2024
    Assignee: THE JOHNS HOPKINS UNIVERSTY
    Inventors: Shiva Razavi, Takanari Inoue, Tianzhi Luo, Douglas Robinson
  • Publication number: 20230304992
    Abstract: Described are conjugates of nucleic acid nanotubes and cells by linking the nanotubes to a cell surface moiety. Devices, kits, systems, and methods comprising the nanotube cell conjugates are also described.
    Type: Application
    Filed: June 29, 2021
    Publication date: September 28, 2023
    Inventors: Rebecca B. Schulman, Sisi Jia, Siew Cheng Phua, Yuta Nihongaki, Yizeng Li, Michael Pacella, Yi Li, Abdul Majeed Mohammed, Sean X. Sun, Takanari Inoue
  • Publication number: 20210145746
    Abstract: This application is directed to methods which allow for encapsulation of an array of biological materials under physiological conditions that are relevant given a biological context and the compositions made using those methods. These reconstituted biological materials encompass: a) purified proteins that can bind to the lipid membranes inside and outside of vesicles based on the electrostatic charge; b) purified cytosolic proteins that position themselves in the lumen of the vesicles, c) mammalian cell extracts with an array of cytosolic protein content, among other contents and d) small biological molecules such as DNA and RNA as well as fluorescent dyes/probes. These vesicles can be used to simulate cells in drug discovery methods as well as useful in administering drugs and other compositions to cells in vitro and in vivo.
    Type: Application
    Filed: December 12, 2018
    Publication date: May 20, 2021
    Inventors: Shiva Razavi, Takanari Inoue, Tianzhi Luo, Douglas Robinson
  • Publication number: 20150379466
    Abstract: A BOM of a product which is used at a plurality of sites is acquired from a BOM input unit. With respect to each component configuration in the BOM, specifications with variations in past demand at or above a given level are accepted as variation specification information. On the basis of the variation specification information, the component specification to be segmented is extracted from the BOM and a BOM to be changed is generated. On the basis of the BOM to be changed, the component configuration of the BOM is segmented and reconfigured, a changed BOM is generated, and the changed BOM is outputted.
    Type: Application
    Filed: December 6, 2013
    Publication date: December 31, 2015
    Inventors: Kentaro TAGUCHI, Akihisa TSUJIBE, Takanari INOUE
  • Publication number: 20150254590
    Abstract: The objective of the present invention is to provide, in the case of recreating a procurement plan, a technology which can create a procurement plan appropriate for the situation even without a skilled operator. A procurement plan creation device according to the present invention has predefined definitions for second constraint conditions in which constraint conditions related to a procurement plan have been relaxed, and creates a plurality of second procurement plans according to combinations of the second constraint conditions and presents the plurality of second procurement plans to an operator (see FIG. 15).
    Type: Application
    Filed: November 9, 2012
    Publication date: September 10, 2015
    Applicant: HITACHI, LTD.
    Inventors: Akihisa Tsujibe, Kentaro Taguchi, Takanari Inoue
  • Publication number: 20120278204
    Abstract: A device for supporting goods delivery schedule coordination includes: a storage unit retaining information of a delivery schedule and transportation lead time; a computation unit having a transportation lead-time converting unit which calculates the shipment date in the delivery schedule and stores that as an updated delivery schedule; an output unit which outputs by a screen the information of the updated delivery schedule based on two types of timing of arrival-date basis and shipment-date basis; and a control unit having a schedule-coordination-information receiving unit which receives information of the delivery schedule requested to be coordinated and stores that as a coordination-requested schedule. The computation unit further has a schedule-coordinatable-period calculating unit which stores the delivery schedule included in the coordinatable period as a coordinatable period. The output unit distinguishably displays a range about the coordinatable period.
    Type: Application
    Filed: February 2, 2012
    Publication date: November 1, 2012
    Inventors: Maho URANO, Takahiro OGAWA, Takanari INOUE, Satoshi KATSUBE
  • Patent number: 6656927
    Abstract: A compound represented by the general formula (I) or a salt thereof, wherein R represents a group represented by the following formula (A), (B) or (C) wherein R1 and R2 independently represent a C1-6 alkyl group, R3 represents an amino group, a mono(C1-6 alkyl)amino group, a di(C1-6 alkyl)amino group or a C1-6 alkoxy group and X-represents an anion, and n represents an integer of 2 to 5. The compound or a salt is useful as a ligand of inositol-1,4,5-trisphosphate (IP3) receptor.
    Type: Grant
    Filed: November 30, 2001
    Date of Patent: December 2, 2003
    Assignees: Daiichi Pharmaceutical., Ltd.
    Inventors: Tetsuo Nagano, Kazuya Kikuchi, Takanari Inoue, Masamitsu Iino, Kenzo Hirose